文献速递糖尿病肥胖与代谢综合征

血浆胆汁酸与胰岛素抵抗及内脏和肝脏脂肪的关系比总体脂肪更密切

Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity.
PubMed 文献 · J Clin Endocrinol Metab · 2021-01-01

结果显示,胰岛素抵抗和2型糖尿病患者的血浆总胆汁酸升高,且胆汁酸与腰围、内脏脂肪正相关,与胰岛素敏感性、腹部皮下脂肪、脂联素及肝脏脂肪(CT值)负相关。

要点

  • 胰岛素抵抗和2型糖尿病者血浆总胆汁酸高于胰岛素敏感的超重/肥胖者。
  • 胆汁酸与内脏脂肪正相关,与胰岛素敏感性和皮下脂肪负相关。
  • 2型糖尿病患者结合型胆汁酸进一步升高。

核心结论

  • 血浆胆汁酸浓度与腹部、内脏和肝脏脂肪相关,但其在胰岛素抵抗中的病因学作用尚待验证。

主要发现

  • 超重/肥胖且胰岛素抵抗组葡萄糖输注率/去脂体重显著低于瘦和超重/肥胖但胰岛素敏感组,内脏和肝脏脂肪更高,而两组总体脂肪相似。
  • 总胆汁酸浓度在超重/肥胖且胰岛素抵抗组(2.62 ± 0.333 mmol/L,P = .03)和2型糖尿病组(3.36 ± 0.582 mmol/L,P < .001)高于超重/肥胖但胰岛素敏感组(1.16 ± 0.143 mmol/L),而超重/肥胖但胰岛素敏感组与瘦组(2.31 ± 0.329 mmol/L)相似。
  • 总胆汁酸与腰围(R = 0.245,P = .041)、内脏脂肪(R = 0.360,P = .002)和成纤维细胞生长因子21(R = 0.341,P = .004)正相关。
  • 总胆汁酸与胰岛素敏感性(R = -0.395,P = .001)、腹部皮下脂肪(R = -0.352,P = .003)、脂联素(R = -0.375,P = .001)和肝脏脂肪(CT值,R = -0.245,P = .04)负相关。
  • 2型糖尿病组结合型胆汁酸进一步升高(P < .001)。

临床怎么用

  • 在临床评估中,血浆胆汁酸可能有助于识别与内脏和肝脏脂肪相关的胰岛素抵抗表型,但其病因学意义尚未确立。

局限性

  • 胆汁酸在胰岛素抵抗中的病因学作用尚待验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: The etiological mechanism of bile acid (BA) effects on insulin resistance and obesity is unknown. OBJECTIVE: This work aimed to determine whether plasma BAs are elevated in human obesity and/or insulin resistance. METHODS: This observational study was conducted at an academic research center. Seventy-one adult volunteers formed 4 groups: lean insulin-sensitive (body mass index [BMI] ≤ 25 kg/m2, Homeostatic Model Assessment of Insulin Resistance [HOMA-IR] < 2.0, n = 19), overweight/obese nondiabetic who were either insulin sensitive (Obsensitive, BMI > 25 kg/m2, HOMA-IR < 1.5, n = 11) or insulin resistant (Obresistant, BMI > 25 kg/m2, HOMA-IR > 3.0, n = 20), and type 2 diabetes (T2D, n = 21). Main outcome measures included insulin sensitivity by hyperinsulinemic-euglycemic clamp, body composition by dual energy x-ray absorptiometry, abdominal fat distribution, and liver density by computed tomography and plasma BA. RESULTS: In the Obresistant group, glucose infusion rate/fat-free mass (GIR/FFM, an inverse measure of insulin resistance) was significantly lower, and visceral and liver fat higher, compared to lean and Obsensitive individuals, despite similar total adiposity in Obresistant and Obsensitive. Total BA concentrations were higher in Obresistant (2.62 ± 0.333 mmol/L, P = .03) and T2D (3.36 ± 0.582 mmol/L, P < .001) vs Obsensitive (1.16 ± 0.143 mmol/L), but were similar between Obsensitive and lean (2.31 ± 0.329 mmol/L) individuals. Total BAs were positively associated with waist circumference (R = 0.245, P = .041), visceral fat (R = 0.360, P = .002), and fibroblast growth factor 21 (R = 0.341, P = .004) and negatively associated with insulin sensitivity (R = -0.395, P = .001), abdominal subcutaneous fat (R = -0.352, P = .003), adiponectin (R = -0.375, P = .001), and liver fat (Hounsfield units, an inverse marker of liver fat, R = -0.245, P = .04). Conjugated BAs were additionally elevated in T2D individuals (P < .001). CONCLUSIONS: BA concentrations correlated with abdominal, visceral, and liver fat in humans, though an etiological role in insulin resistance remains to be verified.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Bishay RH, Tonks KT, George J, et al. Plasma Bile Acids More Closely Align With Insulin Resistance, Visceral and Hepatic Adiposity Than Total Adiposity. J Clin Endocrinol Metab. 2021. PMID: 33347566. doi:10.1210/clinem/dgaa940

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。